Mulhern, CM;
Hong, Y;
Omoyinmi, E;
Jacques, T;
D'Arco, F;
Hemingway, C;
Brogan, PA;
(2019)
Janus kinase 1/2 inhibition for the treatment of autoinflammation associated with heterozygous TNFAIP3 mutation.
Journal of Allergy and Clinical Immunology
, 144
(3)
863-866.e5.
10.1016/j.jaci.2019.05.026.
Preview |
Text
1-s2.0-S0091674919307456-main.pdf - Published Version Download (2MB) | Preview |
Abstract
We report a case of autoinflammation caused by a heterozygous variant in TNFAIP3 manifesting as progressive neuroinflammation. Mutant A20 protein failed to control interferon-dependent transcription. We demonstrate excellent therapeutic response to Janus kinase inhibition.
Archive Staff Only
View Item |